GSA Capital Partners’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$336K Buy
+2,461
New +$302K 0.02% 1232
2025
Q4
– Sell
-7,449
Closed -$996K – 2017
2025
Q3
$996K Buy
7,449
+3,241
+77% +$394K 0.08% 400
2025
Q2
$523K Buy
4,208
+993
+31% +$126K 0.04% 888
2025
Q1
$409K Buy
+3,215
New +$495K 0.04% 935
2024
Q2
– Sell
-1,794
Closed -$330K – 1963
2024
Q1
$330K Buy
+1,794
New +$342K 0.03% 1159
2019
Q4
– Sell
-6,012
Closed -$461K – 1676
2019
Q3
$461K Buy
6,012
+3,096
+106% +$271K 0.06% 604
2019
Q2
$251K Buy
+2,916
New +$199K 0.03% 1113
2019
Q1
– Sell
-8,277
Closed -$437K – 1652
2018
Q4
$437K Buy
8,277
+4,244
+105% +$249K 0.05% 632
2018
Q3
$224K Sell
4,033
-1,290
-24% -$66.5K 0.01% 1446
2018
Q2
$250K Buy
+5,323
New +$219K 0.01% 1459
2018
Q1
– Sell
-6,507
Closed -$236K – 1784
2017
Q4
$236K Buy
+6,507
New +$236K 0.01% 1342
2016
Q4
– Sell
-95,345
Closed -$2.88M – 1935
2016
Q3
$2.88M Sell
95,345
-18,778
-16% -$567K 0.15% 115
2016
Q2
$3.12M Sell
114,123
-6,292
-5% -$161K 0.17% 93
2016
Q1
$3.23M Sell
120,415
-11,989
-9% -$293K 0.21% 54
2015
Q4
$3.75M Buy
132,404
+12,883
+11% +$372K 0.18% 75
2015
Q3
$3.33M Buy
119,521
+24,277
+25% +$877K 0.16% 98
2015
Q2
$3.93M Sell
95,244
-29,691
-24% -$1.09M 0.15% 95
2015
Q1
$3.79M Buy
124,935
+5,532
+5% +$143K 0.15% 97
2014
Q4
$2.36M Buy
119,403
+21,654
+22% +$484K 0.16% 106
2014
Q3
$1.95M Buy
97,749
+21,656
+28% +$456K 0.1% 200
2014
Q2
$1.73M Sell
76,093
-8,100
-10% -$144K 0.08% 339
2014
Q1
$1.08M Sell
84,193
-20,700
-20% -$297K 0.08% 293
2013
Q4
$1.43M Buy
104,893
+16,748
+19% +$200K 0.11% 189
2013
Q3
$978K Buy
88,145
+8,000
+10% +$79.6K 0.08% 362
2013
Q2
$660K Buy
+80,145
New +$673K 0.08% 398

Other funds holding RGEN

GSA Capital Partners's RGEN Position: Q2 2026 in Review

GSA Capital Partners opened a new position in Repligen (RGEN) in Q2 2026: 2,461 shares worth $336K. The stake represents 0.02% of the portfolio and ranks #1232 among its holdings. This is a return to the name: GSA Capital Partners previously reported a position in RGEN as recently as Q3 2025.

GSA Capital Partners first reported a position in RGEN in Q2 2013 and has held it in 25 quarters since. The position peaked at $3.93M in Q2 2015. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • GSA Capital Partners held 2,461 shares of Repligen worth $336K as of Q2 2026.
  • Repligen was a new GSA Capital Partners position in Q2 2026.
  • Repligen made up 0.02% of GSA Capital Partners's portfolio in Q2 2026, its #1232 holding.
  • GSA Capital Partners first reported a position in Repligen in Q2 2013 and has held it in 25 quarters since.
  • GSA Capital Partners's Repligen position peaked at $3.93M in Q2 2015.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.